Patent · US Active

Immunogenic polypeptides encoded by MAGE minigenes and uses thereof

US8257717B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignees

Sanofi Pasteur, Inc. · US
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

Neil Berinstein · Toronto, CA
James Tartaglia · Schenectady, US
John A. Tine · Scotia, US
Philippe Moingeon · Verrières-le-Buisson, FR
Thierry Boon-Falleur · Brussels, BE
Pierre Vander Bruggen · Brussels, BE

Key dates

Filing date	Oct 27, 2010
Grant date	Sep 4, 2012
Priority date	—
Expiry date	Oct 27, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2799/023
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention discloses immunogenic polypeptides comprising several MAGE-specific antigen epitopes selected from different (i.e. discrete) members of the MAGE protein family, nucleic acids coding therefor, recombinant viruses and/or cells comprising said nucleic acids, and compositions thereof. Methods for eliciting or inducing MAGE-specific immune responses utilizing the aforementioned immunogenic agents are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.